These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6380502)

  • 1. Vascular serotonin receptors. Correlation with 5-HT1 and 5-HT2 binding sites.
    Peroutka SJ
    Biochem Pharmacol; 1984 Aug; 33(15):2349-53. PubMed ID: 6380502
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic receptor subtypes and vascular reactivity.
    Van Nueten JM; Leysen JE; de Clerck F; Vanhoutte PM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S564-74. PubMed ID: 6210424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
    Terrón JA
    Proc West Pharmacol Soc; 1996; 39():23-5. PubMed ID: 8895957
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors.
    Peroutka SJ; Noguchi M; Tolner DJ; Allen GS
    Brain Res; 1983 Jan; 259(2):327-30. PubMed ID: 6824943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.
    Leff P; Martin GR; Morse JM
    Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractions to 5-hydroxytryptamine in human coronary artery and human saphenous vein.
    Borton M; Neligan M; Wood F; Dervan P; Goggins K; Docherty JR
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):107S-108S. PubMed ID: 2268504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
    Hicks PE; Schoemaker H; Langer SZ
    Eur J Pharmacol; 1984 Oct; 105(3-4):339-42. PubMed ID: 6150862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT receptors in rat jugular vein: information from RT-PCR and operational studies.
    Pulido-Rios TM; Calixto JJ; Martin GR; Leung E
    Ann N Y Acad Sci; 1998 Dec; 861():260-1. PubMed ID: 9928278
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle.
    Myers JH; Mecca TE; Webb RC
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S44-8. PubMed ID: 2412057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the thromboxane A2-mimetic U46619 on 5-HT1-like and 5-HT2 receptor-mediated contraction of the rabbit isolated femoral artery.
    MacLennan SJ; Martin GR
    Br J Pharmacol; 1992 Oct; 107(2):418-21. PubMed ID: 1422590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
    Cohen ML; Colbert WE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of serotonin receptors on hand vein.
    Panconesi A; Andreini R; Del Bianco PL; Franchi G; Sicuteri F
    Pharmacol Res Commun; 1988 May; 20(5):433-4. PubMed ID: 3420150
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for the putative 5-HT7 receptor mediating direct relaxation to 5-hydroxytryptamine in canine cerebral blood vessels.
    Terrón JA
    Ann N Y Acad Sci; 1998 Dec; 861():283. PubMed ID: 9928292
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of serotonin agonists and antagonists.
    Saxena PR; Villalón CM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S17-34. PubMed ID: 1702484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the relaxant 5-HT receptor in the dog basilar artery by the high-affinity 5-HT7 receptor ligand, LY215840.
    Terrón JA
    Proc West Pharmacol Soc; 1998; 41():129-30. PubMed ID: 9836268
    [No Abstract]   [Full Text] [Related]  

  • 17. Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.
    Tadipatri S; Feniuk W; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):322-8. PubMed ID: 1422584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system.
    Cambridge D; Whiting MV; Butterfield LJ; Marston C
    Br J Pharmacol; 1995 Mar; 114(5):961-8. PubMed ID: 7780651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.
    Saxena PR; Lawang A
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites.
    Hamel E; Bouchard D
    Br J Pharmacol; 1991 Jan; 102(1):227-33. PubMed ID: 2043924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.